Art

J-GLOBAL ID：200902197948136465   Reference number：99A0732239

Interferon Alfa-2a Treatment for Chronic Hepatitis C without Cirrhosis and Its Effects on the Incidence of Hepatocellular Carcinoma.

肝硬変のない慢性C型肝炎に対するインターフェロンα-2a治療と肝細胞癌発症に対する効果

Author (9)： OMAGARI K (Nagasaki Univ. School of Medicine, Nagasaki, JPN) ,  IKUNO N (Nagasaki Univ. School of Medicine, Nagasaki, JPN) ,  IMANISHI T (Koebaru Chuo Hospital, Nagasaki, JPN) ,  HAYASHIDA K (Higashi-Saga National Hospital, Saga, JPN) ,  INOUE K (Shunkai-kai Inoue Hospital, Nagasaki, JPN) ,  SENJU M (Sasebo Senju Hospital, Nagasaki, JPN) ,  MORI N (Hokusho Chuo Hospital, Nagasaki, JPN) ,  TANAKA T (Imari Municipal Hospital, Saga, JPN) ,  KOHNO S (Nagasaki Univ. School of Medicine, Nagasaki, JPN)
Material： Journal of Infection and Chemotherapy  (J Infect Chemother)
Volume： 4  Issue： 4  Page： 209-213  Publication year： Dec. 1998 
JST Material Number： L2852A  ISSN： 1341-321X  Document type： Article
Article type： 原著論文  Country of issue： United Kingdom (GBR)  Language： ENGLISH (EN)

Thesaurus term： *chronic hepatitis C ,...

   To see more with JDream III (charged).   {{ this.onShowAbsJLink("http://jdream3.com/lp/jglobal/index.html?docNo=99A0732239&from=J-GLOBAL&jstjournalNo=L2852A") }}

JST classification (1)： Drug therapy(=pharmacotherapy)for digestive system diseases  (GH05020G)

Reference (19)：

• CHOO, QL. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science. 1989, 244, 359-362
• NUSHIOKA, K. A high prevalence of antibody to the hepatitis C virus in patients with hepatocellular carcinoma in Japan. Cancer. 1991, 67, 429-433
• SHARARA, AI. Ann Intern Med. 1996, 125, 658-668
• HOOFNAGLE, JH. The treatment of chronic viral hepatitis. N Engl J Med. 1997, 336, 347-356
• NISHIGUCHI, S. Randomized trial if effects of interferon-alpha on incidence of hepatocellular carcinoma in choronic active hepatitis C with cirrhosis. Lancet. 1995, 346, 1051-1055

Terms in the title (6)： 肝硬変 ,  慢性C型肝炎 ,  インターフェロンα-2a ,  治療 ,  肝細胞癌 ,  発症